Pharmaceutical Company CEO Developing $100 Alternative To EpiPen After 'Shameful' Price Hike

September 4, 2016

Mark Baum, CEO of Imprimis Pharmaceuticals who previously came out with a $1 alternative to Martin Shkreli's AIDS drug after 5000% price hike, is now going to take on Mylan and is plotting to offer a $100 EpiPen alternative.

epipen alternative
Mark Baum / Imprimis Pharmceuticals

Baum believes the relentless EpiPen price hikes are "shameful" and plans to have a compounded version of the allergy treatment by the end of the year.

"I don't need to make $19 million a year," Baum said, referring to the big pay package Mylan's CEO Heather Bresch took home last year.

"Tonight when I go home I'm going to eat a nice piece of fish and the fish I eat isn't any better or worse than what she is going to eat."

Like us on Facebook!

Click Here For The Most Popular On Sunny Skyz

feel good videoThis Guy's Card Trick Is So Good It Makes Penn MAD!

feel good storiesThis Restaurant Only Hires Servers With Dementia So You Never Know What You're Getting

feel good storiesTim Tebow's Act Of Kindness At A Baseball Game Will Warm Your Heart

feel good storiesThis Hairy Chest Women's Swimsuit Is Selling Like Crazy

feel good storiesIf You've Never Seen A Husky Without Body Hair, Here You Go

feel good storiesWendy's Got Into A Hilarious Sign Battle With Pure Water

feel good videoThis Guy's Card Trick Is So Good It Makes Penn MAD!

feel good videoDisabled Former Marine Sees His Grandson In Uniform For The First Time

feel good videoDad Loses Son's Lunchbox And Brings Home A Toolbox. Mom's Not Impressed, Then She Flips It Over

feel good videoThis Is What Happened When A Lost Kitten Strayed Into A Raccoon Feeding Area

feel good videoBaby Elephant Gets Frightened By Goat, Screams And Runs For Its Life